nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—osteoarthritis—Prednisone—hematologic cancer	0.205	1	CpDpCtD
Flurbiprofen—UGT1A1—hematologic cancer	0.144	0.803	CbGaD
Flurbiprofen—Ibuprofen—Procarbazine—hematologic cancer	0.107	0.572	CrCrCtD
Flurbiprofen—Ibuprofen—Melphalan—hematologic cancer	0.056	0.301	CrCrCtD
Flurbiprofen—ABCC4—Tioguanine—hematologic cancer	0.0369	0.144	CbGbCtD
Flurbiprofen—ALB—hematologic cancer	0.0354	0.197	CbGaD
Flurbiprofen—L-Phenylalanine—Melphalan—hematologic cancer	0.0238	0.127	CrCrCtD
Flurbiprofen—PTGS2—Lenalidomide—hematologic cancer	0.0198	0.0772	CbGbCtD
Flurbiprofen—ABCC4—Mercaptopurine—hematologic cancer	0.0153	0.0596	CbGbCtD
Flurbiprofen—UGT1A1—Nilotinib—hematologic cancer	0.0135	0.0524	CbGbCtD
Flurbiprofen—UGT1A9—Irinotecan—hematologic cancer	0.0113	0.044	CbGbCtD
Flurbiprofen—UGT2B7—Epirubicin—hematologic cancer	0.011	0.0428	CbGbCtD
Flurbiprofen—PTGS2—Thalidomide—hematologic cancer	0.0106	0.0412	CbGbCtD
Flurbiprofen—PTGS1—Bortezomib—hematologic cancer	0.0103	0.04	CbGbCtD
Flurbiprofen—UGT1A1—Irinotecan—hematologic cancer	0.00926	0.036	CbGbCtD
Flurbiprofen—PTGS1—Thalidomide—hematologic cancer	0.00895	0.0348	CbGbCtD
Flurbiprofen—PTGS1—Ifosfamide—hematologic cancer	0.00788	0.0306	CbGbCtD
Flurbiprofen—PTGS1—Imatinib—hematologic cancer	0.00752	0.0293	CbGbCtD
Flurbiprofen—UGT1A1—Etoposide—hematologic cancer	0.00741	0.0288	CbGbCtD
Flurbiprofen—PTGS2—Triamcinolone—hematologic cancer	0.00734	0.0286	CbGbCtD
Flurbiprofen—CYP2C9—Bexarotene—hematologic cancer	0.00674	0.0262	CbGbCtD
Flurbiprofen—PTGS2—Betamethasone—hematologic cancer	0.0063	0.0245	CbGbCtD
Flurbiprofen—ALB—Imatinib—hematologic cancer	0.00562	0.0219	CbGbCtD
Flurbiprofen—CYP2C9—Idarubicin—hematologic cancer	0.00559	0.0217	CbGbCtD
Flurbiprofen—ABCC4—Methotrexate—hematologic cancer	0.00501	0.0195	CbGbCtD
Flurbiprofen—PTGS2—Cisplatin—hematologic cancer	0.00454	0.0177	CbGbCtD
Flurbiprofen—PTGS2—Etoposide—hematologic cancer	0.00446	0.0173	CbGbCtD
Flurbiprofen—CYP2C9—Bortezomib—hematologic cancer	0.00413	0.0161	CbGbCtD
Flurbiprofen—PTGS1—Etoposide—hematologic cancer	0.00376	0.0146	CbGbCtD
Flurbiprofen—ALB—Prednisone—hematologic cancer	0.0037	0.0144	CbGbCtD
Flurbiprofen—PTGS2—Dexamethasone—hematologic cancer	0.00366	0.0143	CbGbCtD
Flurbiprofen—CYP2C9—Thalidomide—hematologic cancer	0.0036	0.014	CbGbCtD
Flurbiprofen—ALB—Irinotecan—hematologic cancer	0.00351	0.0137	CbGbCtD
Flurbiprofen—CYP2C9—Teniposide—hematologic cancer	0.00344	0.0134	CbGbCtD
Flurbiprofen—CYP2C9—Ifosfamide—hematologic cancer	0.00317	0.0123	CbGbCtD
Flurbiprofen—CYP2C9—Imatinib—hematologic cancer	0.00303	0.0118	CbGbCtD
Flurbiprofen—CYP2C9—Nilotinib—hematologic cancer	0.00275	0.0107	CbGbCtD
Flurbiprofen—SLC22A6—Methotrexate—hematologic cancer	0.00218	0.00849	CbGbCtD
Flurbiprofen—ALB—Methotrexate—hematologic cancer	0.00186	0.00723	CbGbCtD
Flurbiprofen—PTGS2—ovarian follicle—hematologic cancer	0.00174	0.237	CbGeAlD
Flurbiprofen—CYP2C9—Cisplatin—hematologic cancer	0.00154	0.006	CbGbCtD
Flurbiprofen—CYP2C9—Dexamethasone—hematologic cancer	0.00125	0.00485	CbGbCtD
Flurbiprofen—UGT2B4—lung—hematologic cancer	0.000711	0.0966	CbGeAlD
Flurbiprofen—UGT1A1—hematopoietic system—hematologic cancer	0.000573	0.0779	CbGeAlD
Flurbiprofen—UGT1A1—blood—hematologic cancer	0.00038	0.0516	CbGeAlD
Flurbiprofen—ABCC4—hematopoietic system—hematologic cancer	0.000374	0.0507	CbGeAlD
Flurbiprofen—UGT2B7—testis—hematologic cancer	0.000369	0.0502	CbGeAlD
Flurbiprofen—ABCC4—blood—hematologic cancer	0.000248	0.0336	CbGeAlD
Flurbiprofen—CYP2C9—hematopoietic system—hematologic cancer	0.000241	0.0327	CbGeAlD
Flurbiprofen—ABCC4—bone marrow—hematologic cancer	0.000239	0.0325	CbGeAlD
Flurbiprofen—PTGS1—hematopoietic system—hematologic cancer	0.00022	0.0299	CbGeAlD
Flurbiprofen—ABCC4—lung—hematologic cancer	0.000217	0.0295	CbGeAlD
Flurbiprofen—ALB—testis—hematologic cancer	0.000211	0.0287	CbGeAlD
Flurbiprofen—PTGS2—hematopoietic system—hematologic cancer	0.00021	0.0286	CbGeAlD
Flurbiprofen—Suprofen—UGT1A1—hematologic cancer	0.000205	0.231	CrCbGaD
Flurbiprofen—ABCC4—testis—hematologic cancer	0.000205	0.0278	CbGeAlD
Flurbiprofen—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000176	0.21	CbGdCrCtD
Flurbiprofen—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000176	0.21	CbGdCrCtD
Flurbiprofen—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000172	0.205	CbGdCrCtD
Flurbiprofen—Naproxen—UGT1A1—hematologic cancer	0.000161	0.181	CrCbGaD
Flurbiprofen—CYP2C9—blood—hematologic cancer	0.00016	0.0217	CbGeAlD
Flurbiprofen—ALB—lymph node—hematologic cancer	0.000153	0.0208	CbGeAlD
Flurbiprofen—ABCC4—lymph node—hematologic cancer	0.000148	0.0202	CbGeAlD
Flurbiprofen—PTGS1—blood—hematologic cancer	0.000146	0.0198	CbGeAlD
Flurbiprofen—PTGS2—blood—hematologic cancer	0.000139	0.0189	CbGeAlD
Flurbiprofen—PTGS2—bone marrow—hematologic cancer	0.000135	0.0183	CbGeAlD
Flurbiprofen—PTGS1—lung—hematologic cancer	0.000128	0.0173	CbGeAlD
Flurbiprofen—PTGS2—lung—hematologic cancer	0.000122	0.0166	CbGeAlD
Flurbiprofen—Ibuprofen—BCL2—hematologic cancer	0.000121	0.136	CrCbGaD
Flurbiprofen—PTGS1—testis—hematologic cancer	0.000121	0.0164	CbGeAlD
Flurbiprofen—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000106	0.126	CbGdCrCtD
Flurbiprofen—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000106	0.126	CbGdCrCtD
Flurbiprofen—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000104	0.124	CbGdCrCtD
Flurbiprofen—Ibuprofen—UGT1A1—hematologic cancer	0.000103	0.116	CrCbGaD
Flurbiprofen—PTGS1—lymph node—hematologic cancer	8.74e-05	0.0119	CbGeAlD
Flurbiprofen—PTGS2—lymph node—hematologic cancer	8.35e-05	0.0113	CbGeAlD
Flurbiprofen—Diflunisal—ALB—hematologic cancer	5.8e-05	0.0652	CrCbGaD
Flurbiprofen—Fenoprofen—ALB—hematologic cancer	4.33e-05	0.0487	CrCbGaD
Flurbiprofen—Naproxen—ALB—hematologic cancer	3.95e-05	0.0444	CrCbGaD
Flurbiprofen—Warfarin—ALB—hematologic cancer	3.31e-05	0.0373	CrCbGaD
Flurbiprofen—Ketoprofen—ALB—hematologic cancer	2.56e-05	0.0288	CrCbGaD
Flurbiprofen—Ibuprofen—ALB—hematologic cancer	2.52e-05	0.0283	CrCbGaD
Flurbiprofen—Ibuprofen—ABCB1—hematologic cancer	2.4e-05	0.027	CrCbGaD
Flurbiprofen—Nitrazepam—ABCB1—hematologic cancer	2.08e-05	0.0234	CrCbGaD
Flurbiprofen—Diazepam—ALB—hematologic cancer	1.54e-05	0.0173	CrCbGaD
Flurbiprofen—Diazepam—ABCB1—hematologic cancer	1.47e-05	0.0165	CrCbGaD
Flurbiprofen—Hypersensitivity—Prednisolone—hematologic cancer	8.12e-06	6.83e-05	CcSEcCtD
Flurbiprofen—Pharyngitis—Doxorubicin—hematologic cancer	8.09e-06	6.81e-05	CcSEcCtD
Flurbiprofen—Dyspepsia—Dexamethasone—hematologic cancer	8.09e-06	6.81e-05	CcSEcCtD
Flurbiprofen—Dyspepsia—Betamethasone—hematologic cancer	8.09e-06	6.81e-05	CcSEcCtD
Flurbiprofen—Urticaria—Triamcinolone—hematologic cancer	8.05e-06	6.77e-05	CcSEcCtD
Flurbiprofen—Asthenia—Etoposide—hematologic cancer	8.01e-06	6.74e-05	CcSEcCtD
Flurbiprofen—Body temperature increased—Triamcinolone—hematologic cancer	8.01e-06	6.74e-05	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Prednisone—hematologic cancer	8.01e-06	6.73e-05	CcSEcCtD
Flurbiprofen—Oedema—Prednisone—hematologic cancer	8.01e-06	6.73e-05	CcSEcCtD
Flurbiprofen—Angiopathy—Epirubicin—hematologic cancer	8e-06	6.72e-05	CcSEcCtD
Flurbiprofen—Decreased appetite—Betamethasone—hematologic cancer	7.99e-06	6.72e-05	CcSEcCtD
Flurbiprofen—Decreased appetite—Dexamethasone—hematologic cancer	7.99e-06	6.72e-05	CcSEcCtD
Flurbiprofen—Nausea—Irinotecan—hematologic cancer	7.98e-06	6.71e-05	CcSEcCtD
Flurbiprofen—Nausea—Mitoxantrone—hematologic cancer	7.98e-06	6.71e-05	CcSEcCtD
Flurbiprofen—Infection—Prednisone—hematologic cancer	7.95e-06	6.69e-05	CcSEcCtD
Flurbiprofen—Chills—Epirubicin—hematologic cancer	7.91e-06	6.65e-05	CcSEcCtD
Flurbiprofen—Pruritus—Etoposide—hematologic cancer	7.9e-06	6.65e-05	CcSEcCtD
Flurbiprofen—Shock—Prednisone—hematologic cancer	7.88e-06	6.62e-05	CcSEcCtD
Flurbiprofen—Arrhythmia—Epirubicin—hematologic cancer	7.87e-06	6.62e-05	CcSEcCtD
Flurbiprofen—Pain—Betamethasone—hematologic cancer	7.86e-06	6.61e-05	CcSEcCtD
Flurbiprofen—Pain—Dexamethasone—hematologic cancer	7.86e-06	6.61e-05	CcSEcCtD
Flurbiprofen—Visual impairment—Doxorubicin—hematologic cancer	7.86e-06	6.61e-05	CcSEcCtD
Flurbiprofen—Tachycardia—Prednisone—hematologic cancer	7.81e-06	6.57e-05	CcSEcCtD
Flurbiprofen—Alopecia—Epirubicin—hematologic cancer	7.79e-06	6.55e-05	CcSEcCtD
Flurbiprofen—Nausea—Gemcitabine—hematologic cancer	7.77e-06	6.53e-05	CcSEcCtD
Flurbiprofen—Vomiting—Cisplatin—hematologic cancer	7.75e-06	6.52e-05	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Prednisone—hematologic cancer	7.74e-06	6.51e-05	CcSEcCtD
Flurbiprofen—Erythema multiforme—Doxorubicin—hematologic cancer	7.71e-06	6.48e-05	CcSEcCtD
Flurbiprofen—Rash—Cisplatin—hematologic cancer	7.69e-06	6.47e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Cisplatin—hematologic cancer	7.68e-06	6.46e-05	CcSEcCtD
Flurbiprofen—Diarrhoea—Etoposide—hematologic cancer	7.64e-06	6.43e-05	CcSEcCtD
Flurbiprofen—Anorexia—Prednisone—hematologic cancer	7.63e-06	6.42e-05	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Methotrexate—hematologic cancer	7.61e-06	6.4e-05	CcSEcCtD
Flurbiprofen—Tinnitus—Doxorubicin—hematologic cancer	7.6e-06	6.39e-05	CcSEcCtD
Flurbiprofen—Anaemia—Methotrexate—hematologic cancer	7.58e-06	6.37e-05	CcSEcCtD
Flurbiprofen—Feeling abnormal—Dexamethasone—hematologic cancer	7.58e-06	6.37e-05	CcSEcCtD
Flurbiprofen—Feeling abnormal—Betamethasone—hematologic cancer	7.58e-06	6.37e-05	CcSEcCtD
Flurbiprofen—Flatulence—Epirubicin—hematologic cancer	7.56e-06	6.36e-05	CcSEcCtD
Flurbiprofen—Tension—Epirubicin—hematologic cancer	7.53e-06	6.33e-05	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.52e-06	6.32e-05	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Betamethasone—hematologic cancer	7.52e-06	6.32e-05	CcSEcCtD
Flurbiprofen—Hypersensitivity—Triamcinolone—hematologic cancer	7.46e-06	6.28e-05	CcSEcCtD
Flurbiprofen—Nervousness—Epirubicin—hematologic cancer	7.45e-06	6.27e-05	CcSEcCtD
Flurbiprofen—Angiopathy—Doxorubicin—hematologic cancer	7.4e-06	6.22e-05	CcSEcCtD
Flurbiprofen—Malaise—Methotrexate—hematologic cancer	7.39e-06	6.22e-05	CcSEcCtD
Flurbiprofen—Dizziness—Etoposide—hematologic cancer	7.39e-06	6.21e-05	CcSEcCtD
Flurbiprofen—Vertigo—Methotrexate—hematologic cancer	7.37e-06	6.19e-05	CcSEcCtD
Flurbiprofen—Leukopenia—Methotrexate—hematologic cancer	7.34e-06	6.17e-05	CcSEcCtD
Flurbiprofen—Chills—Doxorubicin—hematologic cancer	7.32e-06	6.15e-05	CcSEcCtD
Flurbiprofen—Urticaria—Betamethasone—hematologic cancer	7.3e-06	6.14e-05	CcSEcCtD
Flurbiprofen—Urticaria—Dexamethasone—hematologic cancer	7.3e-06	6.14e-05	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.29e-06	6.13e-05	CcSEcCtD
Flurbiprofen—Dizziness—Prednisolone—hematologic cancer	7.29e-06	6.13e-05	CcSEcCtD
Flurbiprofen—Arrhythmia—Doxorubicin—hematologic cancer	7.28e-06	6.13e-05	CcSEcCtD
Flurbiprofen—Asthenia—Triamcinolone—hematologic cancer	7.27e-06	6.11e-05	CcSEcCtD
Flurbiprofen—Abdominal pain—Dexamethasone—hematologic cancer	7.27e-06	6.11e-05	CcSEcCtD
Flurbiprofen—Body temperature increased—Dexamethasone—hematologic cancer	7.27e-06	6.11e-05	CcSEcCtD
Flurbiprofen—Abdominal pain—Betamethasone—hematologic cancer	7.27e-06	6.11e-05	CcSEcCtD
Flurbiprofen—Body temperature increased—Betamethasone—hematologic cancer	7.27e-06	6.11e-05	CcSEcCtD
Flurbiprofen—Nausea—Cisplatin—hematologic cancer	7.24e-06	6.09e-05	CcSEcCtD
Flurbiprofen—Insomnia—Prednisone—hematologic cancer	7.24e-06	6.09e-05	CcSEcCtD
Flurbiprofen—Alopecia—Doxorubicin—hematologic cancer	7.21e-06	6.06e-05	CcSEcCtD
Flurbiprofen—Paraesthesia—Prednisone—hematologic cancer	7.19e-06	6.05e-05	CcSEcCtD
Flurbiprofen—Pruritus—Triamcinolone—hematologic cancer	7.17e-06	6.03e-05	CcSEcCtD
Flurbiprofen—Cough—Methotrexate—hematologic cancer	7.15e-06	6.02e-05	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Epirubicin—hematologic cancer	7.12e-06	5.99e-05	CcSEcCtD
Flurbiprofen—Convulsion—Methotrexate—hematologic cancer	7.1e-06	5.97e-05	CcSEcCtD
Flurbiprofen—Vomiting—Etoposide—hematologic cancer	7.1e-06	5.97e-05	CcSEcCtD
Flurbiprofen—Anaemia—Epirubicin—hematologic cancer	7.09e-06	5.96e-05	CcSEcCtD
Flurbiprofen—Dyspepsia—Prednisone—hematologic cancer	7.05e-06	5.93e-05	CcSEcCtD
Flurbiprofen—Rash—Etoposide—hematologic cancer	7.04e-06	5.92e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Etoposide—hematologic cancer	7.04e-06	5.92e-05	CcSEcCtD
Flurbiprofen—Headache—Etoposide—hematologic cancer	7e-06	5.88e-05	CcSEcCtD
Flurbiprofen—Flatulence—Doxorubicin—hematologic cancer	7e-06	5.88e-05	CcSEcCtD
Flurbiprofen—Myalgia—Methotrexate—hematologic cancer	6.98e-06	5.87e-05	CcSEcCtD
Flurbiprofen—Tension—Doxorubicin—hematologic cancer	6.97e-06	5.86e-05	CcSEcCtD
Flurbiprofen—Decreased appetite—Prednisone—hematologic cancer	6.96e-06	5.85e-05	CcSEcCtD
Flurbiprofen—Rash—Prednisolone—hematologic cancer	6.95e-06	5.84e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Prednisolone—hematologic cancer	6.94e-06	5.84e-05	CcSEcCtD
Flurbiprofen—Malaise—Epirubicin—hematologic cancer	6.92e-06	5.82e-05	CcSEcCtD
Flurbiprofen—Headache—Prednisolone—hematologic cancer	6.9e-06	5.8e-05	CcSEcCtD
Flurbiprofen—Discomfort—Methotrexate—hematologic cancer	6.9e-06	5.8e-05	CcSEcCtD
Flurbiprofen—Nervousness—Doxorubicin—hematologic cancer	6.89e-06	5.8e-05	CcSEcCtD
Flurbiprofen—Vertigo—Epirubicin—hematologic cancer	6.89e-06	5.8e-05	CcSEcCtD
Flurbiprofen—Syncope—Epirubicin—hematologic cancer	6.88e-06	5.79e-05	CcSEcCtD
Flurbiprofen—Leukopenia—Epirubicin—hematologic cancer	6.87e-06	5.78e-05	CcSEcCtD
Flurbiprofen—Constipation—Prednisone—hematologic cancer	6.85e-06	5.76e-05	CcSEcCtD
Flurbiprofen—Palpitations—Epirubicin—hematologic cancer	6.78e-06	5.7e-05	CcSEcCtD
Flurbiprofen—Confusional state—Methotrexate—hematologic cancer	6.75e-06	5.67e-05	CcSEcCtD
Flurbiprofen—Loss of consciousness—Epirubicin—hematologic cancer	6.74e-06	5.67e-05	CcSEcCtD
Flurbiprofen—Dizziness—Triamcinolone—hematologic cancer	6.7e-06	5.63e-05	CcSEcCtD
Flurbiprofen—Cough—Epirubicin—hematologic cancer	6.69e-06	5.63e-05	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Methotrexate—hematologic cancer	6.69e-06	5.63e-05	CcSEcCtD
Flurbiprofen—Convulsion—Epirubicin—hematologic cancer	6.65e-06	5.59e-05	CcSEcCtD
Flurbiprofen—Infection—Methotrexate—hematologic cancer	6.65e-06	5.59e-05	CcSEcCtD
Flurbiprofen—Nausea—Etoposide—hematologic cancer	6.63e-06	5.58e-05	CcSEcCtD
Flurbiprofen—Hypertension—Epirubicin—hematologic cancer	6.62e-06	5.57e-05	CcSEcCtD
Flurbiprofen—Feeling abnormal—Prednisone—hematologic cancer	6.6e-06	5.55e-05	CcSEcCtD
Flurbiprofen—Asthenia—Betamethasone—hematologic cancer	6.6e-06	5.55e-05	CcSEcCtD
Flurbiprofen—Asthenia—Dexamethasone—hematologic cancer	6.6e-06	5.55e-05	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Doxorubicin—hematologic cancer	6.59e-06	5.54e-05	CcSEcCtD
Flurbiprofen—Anaemia—Doxorubicin—hematologic cancer	6.56e-06	5.52e-05	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Methotrexate—hematologic cancer	6.55e-06	5.51e-05	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Prednisone—hematologic cancer	6.55e-06	5.51e-05	CcSEcCtD
Flurbiprofen—Nausea—Prednisolone—hematologic cancer	6.54e-06	5.5e-05	CcSEcCtD
Flurbiprofen—Myalgia—Epirubicin—hematologic cancer	6.53e-06	5.49e-05	CcSEcCtD
Flurbiprofen—Anxiety—Epirubicin—hematologic cancer	6.51e-06	5.47e-05	CcSEcCtD
Flurbiprofen—Pruritus—Betamethasone—hematologic cancer	6.5e-06	5.47e-05	CcSEcCtD
Flurbiprofen—Pruritus—Dexamethasone—hematologic cancer	6.5e-06	5.47e-05	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Methotrexate—hematologic cancer	6.47e-06	5.44e-05	CcSEcCtD
Flurbiprofen—Discomfort—Epirubicin—hematologic cancer	6.45e-06	5.43e-05	CcSEcCtD
Flurbiprofen—Vomiting—Triamcinolone—hematologic cancer	6.44e-06	5.42e-05	CcSEcCtD
Flurbiprofen—Malaise—Doxorubicin—hematologic cancer	6.4e-06	5.38e-05	CcSEcCtD
Flurbiprofen—Rash—Triamcinolone—hematologic cancer	6.39e-06	5.37e-05	CcSEcCtD
Flurbiprofen—Dry mouth—Epirubicin—hematologic cancer	6.39e-06	5.37e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Triamcinolone—hematologic cancer	6.38e-06	5.37e-05	CcSEcCtD
Flurbiprofen—Vertigo—Doxorubicin—hematologic cancer	6.38e-06	5.36e-05	CcSEcCtD
Flurbiprofen—Anorexia—Methotrexate—hematologic cancer	6.38e-06	5.36e-05	CcSEcCtD
Flurbiprofen—Syncope—Doxorubicin—hematologic cancer	6.37e-06	5.35e-05	CcSEcCtD
Flurbiprofen—Urticaria—Prednisone—hematologic cancer	6.36e-06	5.35e-05	CcSEcCtD
Flurbiprofen—Leukopenia—Doxorubicin—hematologic cancer	6.35e-06	5.34e-05	CcSEcCtD
Flurbiprofen—Headache—Triamcinolone—hematologic cancer	6.35e-06	5.34e-05	CcSEcCtD
Flurbiprofen—Body temperature increased—Prednisone—hematologic cancer	6.33e-06	5.32e-05	CcSEcCtD
Flurbiprofen—Abdominal pain—Prednisone—hematologic cancer	6.33e-06	5.32e-05	CcSEcCtD
Flurbiprofen—Confusional state—Epirubicin—hematologic cancer	6.31e-06	5.31e-05	CcSEcCtD
Flurbiprofen—Diarrhoea—Dexamethasone—hematologic cancer	6.29e-06	5.29e-05	CcSEcCtD
Flurbiprofen—Diarrhoea—Betamethasone—hematologic cancer	6.29e-06	5.29e-05	CcSEcCtD
Flurbiprofen—Palpitations—Doxorubicin—hematologic cancer	6.27e-06	5.28e-05	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Epirubicin—hematologic cancer	6.26e-06	5.27e-05	CcSEcCtD
Flurbiprofen—Oedema—Epirubicin—hematologic cancer	6.26e-06	5.27e-05	CcSEcCtD
Flurbiprofen—Hypotension—Methotrexate—hematologic cancer	6.25e-06	5.26e-05	CcSEcCtD
Flurbiprofen—Loss of consciousness—Doxorubicin—hematologic cancer	6.24e-06	5.25e-05	CcSEcCtD
Flurbiprofen—Infection—Epirubicin—hematologic cancer	6.22e-06	5.23e-05	CcSEcCtD
Flurbiprofen—Cough—Doxorubicin—hematologic cancer	6.19e-06	5.21e-05	CcSEcCtD
Flurbiprofen—Shock—Epirubicin—hematologic cancer	6.16e-06	5.18e-05	CcSEcCtD
Flurbiprofen—Convulsion—Doxorubicin—hematologic cancer	6.15e-06	5.17e-05	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Epirubicin—hematologic cancer	6.13e-06	5.16e-05	CcSEcCtD
Flurbiprofen—Hypertension—Doxorubicin—hematologic cancer	6.13e-06	5.15e-05	CcSEcCtD
Flurbiprofen—Tachycardia—Epirubicin—hematologic cancer	6.11e-06	5.14e-05	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.1e-06	5.13e-05	CcSEcCtD
Flurbiprofen—Dizziness—Betamethasone—hematologic cancer	6.08e-06	5.11e-05	CcSEcCtD
Flurbiprofen—Dizziness—Dexamethasone—hematologic cancer	6.08e-06	5.11e-05	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Epirubicin—hematologic cancer	6.05e-06	5.09e-05	CcSEcCtD
Flurbiprofen—Insomnia—Methotrexate—hematologic cancer	6.05e-06	5.09e-05	CcSEcCtD
Flurbiprofen—Myalgia—Doxorubicin—hematologic cancer	6.04e-06	5.08e-05	CcSEcCtD
Flurbiprofen—Anxiety—Doxorubicin—hematologic cancer	6.02e-06	5.06e-05	CcSEcCtD
Flurbiprofen—Nausea—Triamcinolone—hematologic cancer	6.02e-06	5.06e-05	CcSEcCtD
Flurbiprofen—Paraesthesia—Methotrexate—hematologic cancer	6.01e-06	5.05e-05	CcSEcCtD
Flurbiprofen—Discomfort—Doxorubicin—hematologic cancer	5.97e-06	5.02e-05	CcSEcCtD
Flurbiprofen—Anorexia—Epirubicin—hematologic cancer	5.97e-06	5.02e-05	CcSEcCtD
Flurbiprofen—Dyspnoea—Methotrexate—hematologic cancer	5.97e-06	5.02e-05	CcSEcCtD
Flurbiprofen—Somnolence—Methotrexate—hematologic cancer	5.95e-06	5e-05	CcSEcCtD
Flurbiprofen—Dry mouth—Doxorubicin—hematologic cancer	5.91e-06	4.97e-05	CcSEcCtD
Flurbiprofen—Hypersensitivity—Prednisone—hematologic cancer	5.9e-06	4.96e-05	CcSEcCtD
Flurbiprofen—Dyspepsia—Methotrexate—hematologic cancer	5.89e-06	4.95e-05	CcSEcCtD
Flurbiprofen—Hypotension—Epirubicin—hematologic cancer	5.85e-06	4.92e-05	CcSEcCtD
Flurbiprofen—Vomiting—Dexamethasone—hematologic cancer	5.85e-06	4.92e-05	CcSEcCtD
Flurbiprofen—Vomiting—Betamethasone—hematologic cancer	5.85e-06	4.92e-05	CcSEcCtD
Flurbiprofen—Confusional state—Doxorubicin—hematologic cancer	5.84e-06	4.91e-05	CcSEcCtD
Flurbiprofen—Decreased appetite—Methotrexate—hematologic cancer	5.82e-06	4.89e-05	CcSEcCtD
Flurbiprofen—Rash—Dexamethasone—hematologic cancer	5.8e-06	4.87e-05	CcSEcCtD
Flurbiprofen—Rash—Betamethasone—hematologic cancer	5.8e-06	4.87e-05	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Doxorubicin—hematologic cancer	5.79e-06	4.87e-05	CcSEcCtD
Flurbiprofen—Oedema—Doxorubicin—hematologic cancer	5.79e-06	4.87e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Betamethasone—hematologic cancer	5.79e-06	4.87e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Dexamethasone—hematologic cancer	5.79e-06	4.87e-05	CcSEcCtD
Flurbiprofen—Headache—Dexamethasone—hematologic cancer	5.76e-06	4.84e-05	CcSEcCtD
Flurbiprofen—Headache—Betamethasone—hematologic cancer	5.76e-06	4.84e-05	CcSEcCtD
Flurbiprofen—Infection—Doxorubicin—hematologic cancer	5.76e-06	4.84e-05	CcSEcCtD
Flurbiprofen—Asthenia—Prednisone—hematologic cancer	5.74e-06	4.83e-05	CcSEcCtD
Flurbiprofen—Pain—Methotrexate—hematologic cancer	5.72e-06	4.81e-05	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.7e-06	4.8e-05	CcSEcCtD
Flurbiprofen—Shock—Doxorubicin—hematologic cancer	5.7e-06	4.79e-05	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Doxorubicin—hematologic cancer	5.67e-06	4.77e-05	CcSEcCtD
Flurbiprofen—Pruritus—Prednisone—hematologic cancer	5.66e-06	4.76e-05	CcSEcCtD
Flurbiprofen—Insomnia—Epirubicin—hematologic cancer	5.66e-06	4.76e-05	CcSEcCtD
Flurbiprofen—Tachycardia—Doxorubicin—hematologic cancer	5.65e-06	4.76e-05	CcSEcCtD
Flurbiprofen—Paraesthesia—Epirubicin—hematologic cancer	5.62e-06	4.73e-05	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Doxorubicin—hematologic cancer	5.6e-06	4.71e-05	CcSEcCtD
Flurbiprofen—Dyspnoea—Epirubicin—hematologic cancer	5.58e-06	4.69e-05	CcSEcCtD
Flurbiprofen—Somnolence—Epirubicin—hematologic cancer	5.57e-06	4.68e-05	CcSEcCtD
Flurbiprofen—Anorexia—Doxorubicin—hematologic cancer	5.52e-06	4.64e-05	CcSEcCtD
Flurbiprofen—Feeling abnormal—Methotrexate—hematologic cancer	5.51e-06	4.64e-05	CcSEcCtD
Flurbiprofen—Dyspepsia—Epirubicin—hematologic cancer	5.51e-06	4.64e-05	CcSEcCtD
Flurbiprofen—Diarrhoea—Prednisone—hematologic cancer	5.48e-06	4.61e-05	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Methotrexate—hematologic cancer	5.47e-06	4.6e-05	CcSEcCtD
Flurbiprofen—Nausea—Dexamethasone—hematologic cancer	5.46e-06	4.59e-05	CcSEcCtD
Flurbiprofen—Nausea—Betamethasone—hematologic cancer	5.46e-06	4.59e-05	CcSEcCtD
Flurbiprofen—Decreased appetite—Epirubicin—hematologic cancer	5.44e-06	4.58e-05	CcSEcCtD
Flurbiprofen—Hypotension—Doxorubicin—hematologic cancer	5.41e-06	4.55e-05	CcSEcCtD
Flurbiprofen—Pain—Epirubicin—hematologic cancer	5.35e-06	4.5e-05	CcSEcCtD
Flurbiprofen—Constipation—Epirubicin—hematologic cancer	5.35e-06	4.5e-05	CcSEcCtD
Flurbiprofen—Urticaria—Methotrexate—hematologic cancer	5.32e-06	4.47e-05	CcSEcCtD
Flurbiprofen—Dizziness—Prednisone—hematologic cancer	5.29e-06	4.45e-05	CcSEcCtD
Flurbiprofen—Body temperature increased—Methotrexate—hematologic cancer	5.29e-06	4.45e-05	CcSEcCtD
Flurbiprofen—Abdominal pain—Methotrexate—hematologic cancer	5.29e-06	4.45e-05	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.28e-06	4.44e-05	CcSEcCtD
Flurbiprofen—Insomnia—Doxorubicin—hematologic cancer	5.24e-06	4.41e-05	CcSEcCtD
Flurbiprofen—Paraesthesia—Doxorubicin—hematologic cancer	5.2e-06	4.37e-05	CcSEcCtD
Flurbiprofen—Dyspnoea—Doxorubicin—hematologic cancer	5.17e-06	4.34e-05	CcSEcCtD
Flurbiprofen—Feeling abnormal—Epirubicin—hematologic cancer	5.16e-06	4.34e-05	CcSEcCtD
Flurbiprofen—Somnolence—Doxorubicin—hematologic cancer	5.15e-06	4.33e-05	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Epirubicin—hematologic cancer	5.12e-06	4.31e-05	CcSEcCtD
Flurbiprofen—Dyspepsia—Doxorubicin—hematologic cancer	5.1e-06	4.29e-05	CcSEcCtD
Flurbiprofen—Vomiting—Prednisone—hematologic cancer	5.09e-06	4.28e-05	CcSEcCtD
Flurbiprofen—Rash—Prednisone—hematologic cancer	5.05e-06	4.25e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Prednisone—hematologic cancer	5.04e-06	4.24e-05	CcSEcCtD
Flurbiprofen—Decreased appetite—Doxorubicin—hematologic cancer	5.04e-06	4.24e-05	CcSEcCtD
Flurbiprofen—Headache—Prednisone—hematologic cancer	5.02e-06	4.22e-05	CcSEcCtD
Flurbiprofen—Urticaria—Epirubicin—hematologic cancer	4.97e-06	4.18e-05	CcSEcCtD
Flurbiprofen—Pain—Doxorubicin—hematologic cancer	4.95e-06	4.17e-05	CcSEcCtD
Flurbiprofen—Constipation—Doxorubicin—hematologic cancer	4.95e-06	4.17e-05	CcSEcCtD
Flurbiprofen—Abdominal pain—Epirubicin—hematologic cancer	4.95e-06	4.16e-05	CcSEcCtD
Flurbiprofen—Body temperature increased—Epirubicin—hematologic cancer	4.95e-06	4.16e-05	CcSEcCtD
Flurbiprofen—Hypersensitivity—Methotrexate—hematologic cancer	4.93e-06	4.15e-05	CcSEcCtD
Flurbiprofen—Asthenia—Methotrexate—hematologic cancer	4.8e-06	4.04e-05	CcSEcCtD
Flurbiprofen—Feeling abnormal—Doxorubicin—hematologic cancer	4.77e-06	4.01e-05	CcSEcCtD
Flurbiprofen—Nausea—Prednisone—hematologic cancer	4.76e-06	4e-05	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.74e-06	3.98e-05	CcSEcCtD
Flurbiprofen—Pruritus—Methotrexate—hematologic cancer	4.73e-06	3.98e-05	CcSEcCtD
Flurbiprofen—Hypersensitivity—Epirubicin—hematologic cancer	4.61e-06	3.88e-05	CcSEcCtD
Flurbiprofen—Urticaria—Doxorubicin—hematologic cancer	4.6e-06	3.87e-05	CcSEcCtD
Flurbiprofen—Abdominal pain—Doxorubicin—hematologic cancer	4.58e-06	3.85e-05	CcSEcCtD
Flurbiprofen—Body temperature increased—Doxorubicin—hematologic cancer	4.58e-06	3.85e-05	CcSEcCtD
Flurbiprofen—Diarrhoea—Methotrexate—hematologic cancer	4.58e-06	3.85e-05	CcSEcCtD
Flurbiprofen—Asthenia—Epirubicin—hematologic cancer	4.49e-06	3.78e-05	CcSEcCtD
Flurbiprofen—Pruritus—Epirubicin—hematologic cancer	4.43e-06	3.73e-05	CcSEcCtD
Flurbiprofen—Dizziness—Methotrexate—hematologic cancer	4.42e-06	3.72e-05	CcSEcCtD
Flurbiprofen—Diarrhoea—Epirubicin—hematologic cancer	4.28e-06	3.6e-05	CcSEcCtD
Flurbiprofen—Hypersensitivity—Doxorubicin—hematologic cancer	4.27e-06	3.59e-05	CcSEcCtD
Flurbiprofen—Vomiting—Methotrexate—hematologic cancer	4.25e-06	3.58e-05	CcSEcCtD
Flurbiprofen—Rash—Methotrexate—hematologic cancer	4.22e-06	3.55e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Methotrexate—hematologic cancer	4.21e-06	3.54e-05	CcSEcCtD
Flurbiprofen—Headache—Methotrexate—hematologic cancer	4.19e-06	3.52e-05	CcSEcCtD
Flurbiprofen—Asthenia—Doxorubicin—hematologic cancer	4.16e-06	3.5e-05	CcSEcCtD
Flurbiprofen—Dizziness—Epirubicin—hematologic cancer	4.14e-06	3.48e-05	CcSEcCtD
Flurbiprofen—Pruritus—Doxorubicin—hematologic cancer	4.1e-06	3.45e-05	CcSEcCtD
Flurbiprofen—Vomiting—Epirubicin—hematologic cancer	3.98e-06	3.35e-05	CcSEcCtD
Flurbiprofen—Nausea—Methotrexate—hematologic cancer	3.97e-06	3.34e-05	CcSEcCtD
Flurbiprofen—Diarrhoea—Doxorubicin—hematologic cancer	3.96e-06	3.33e-05	CcSEcCtD
Flurbiprofen—Rash—Epirubicin—hematologic cancer	3.95e-06	3.32e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Epirubicin—hematologic cancer	3.94e-06	3.32e-05	CcSEcCtD
Flurbiprofen—Headache—Epirubicin—hematologic cancer	3.92e-06	3.3e-05	CcSEcCtD
Flurbiprofen—Dizziness—Doxorubicin—hematologic cancer	3.83e-06	3.22e-05	CcSEcCtD
Flurbiprofen—Nausea—Epirubicin—hematologic cancer	3.72e-06	3.13e-05	CcSEcCtD
Flurbiprofen—Vomiting—Doxorubicin—hematologic cancer	3.68e-06	3.1e-05	CcSEcCtD
Flurbiprofen—Rash—Doxorubicin—hematologic cancer	3.65e-06	3.07e-05	CcSEcCtD
Flurbiprofen—Dermatitis—Doxorubicin—hematologic cancer	3.65e-06	3.07e-05	CcSEcCtD
Flurbiprofen—Headache—Doxorubicin—hematologic cancer	3.63e-06	3.05e-05	CcSEcCtD
Flurbiprofen—Nausea—Doxorubicin—hematologic cancer	3.44e-06	2.89e-05	CcSEcCtD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.83e-06	6.42e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HSP90AA1—hematologic cancer	2.83e-06	6.42e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ALOX5—hematologic cancer	2.82e-06	6.4e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CD—hematologic cancer	2.82e-06	6.4e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PTPN11—hematologic cancer	2.82e-06	6.38e-05	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PIK3CA—hematologic cancer	2.8e-06	6.35e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.8e-06	6.34e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ACP5—hematologic cancer	2.79e-06	6.32e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CA9—hematologic cancer	2.79e-06	6.32e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—ALB—hematologic cancer	2.79e-06	6.32e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NCOR2—hematologic cancer	2.75e-06	6.24e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—HRAS—hematologic cancer	2.74e-06	6.2e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NUP98—hematologic cancer	2.73e-06	6.2e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—STAT1—hematologic cancer	2.73e-06	6.19e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CG—hematologic cancer	2.73e-06	6.19e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.69e-06	6.09e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.68e-06	6.07e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3R1—hematologic cancer	2.67e-06	6.04e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—CREBBP—hematologic cancer	2.66e-06	6.02e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ADCY7—hematologic cancer	2.65e-06	6.02e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NCOA3—hematologic cancer	2.65e-06	6.02e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTP1—hematologic cancer	2.65e-06	6.01e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—MTHFR—hematologic cancer	2.64e-06	5.99e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—MTHFR—hematologic cancer	2.64e-06	5.99e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NUP214—hematologic cancer	2.64e-06	5.97e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—IDH1—hematologic cancer	2.62e-06	5.94e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.61e-06	5.91e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	2.6e-06	5.88e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCC3—hematologic cancer	2.59e-06	5.88e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—TXN—hematologic cancer	2.59e-06	5.88e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTO1—hematologic cancer	2.59e-06	5.88e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—MTR—hematologic cancer	2.58e-06	5.85e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ABCG2—hematologic cancer	2.58e-06	5.85e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.56e-06	5.81e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—GRB2—hematologic cancer	2.56e-06	5.79e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PDGFA—hematologic cancer	2.55e-06	5.78e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SPHK1—hematologic cancer	2.54e-06	5.75e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ENO2—hematologic cancer	2.53e-06	5.74e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CREBBP—hematologic cancer	2.53e-06	5.74e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CD44—hematologic cancer	2.52e-06	5.72e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NQO1—hematologic cancer	2.52e-06	5.72e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CD—hematologic cancer	2.52e-06	5.71e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KITLG—hematologic cancer	2.51e-06	5.69e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ABCB1—hematologic cancer	2.51e-06	5.69e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.47e-06	5.6e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CB—hematologic cancer	2.46e-06	5.58e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTT1—hematologic cancer	2.46e-06	5.57e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—STAT5A—hematologic cancer	2.46e-06	5.57e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—UGT1A1—hematologic cancer	2.44e-06	5.52e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTM1—hematologic cancer	2.44e-06	5.52e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—NCOR1—hematologic cancer	2.44e-06	5.52e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN2B—hematologic cancer	2.43e-06	5.52e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.42e-06	5.48e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—AKT1—hematologic cancer	2.42e-06	5.48e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—SDC1—hematologic cancer	2.4e-06	5.44e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CD—hematologic cancer	2.4e-06	5.44e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYCS—hematologic cancer	2.39e-06	5.41e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3R1—hematologic cancer	2.38e-06	5.39e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—HSP90AA1—hematologic cancer	2.37e-06	5.38e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SLC22A1—hematologic cancer	2.37e-06	5.37e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CRABP1—hematologic cancer	2.37e-06	5.37e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—ALB—hematologic cancer	2.37e-06	5.37e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CD86—hematologic cancer	2.35e-06	5.34e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.33e-06	5.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HES1—hematologic cancer	2.32e-06	5.26e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—JAK2—hematologic cancer	2.31e-06	5.24e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALOX5—hematologic cancer	2.31e-06	5.24e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NCOR1—hematologic cancer	2.31e-06	5.23e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.3e-06	5.21e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.29e-06	5.2e-05	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—AKT1—hematologic cancer	2.29e-06	5.18e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FGF1—hematologic cancer	2.28e-06	5.17e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3R1—hematologic cancer	2.27e-06	5.14e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FOXO1—hematologic cancer	2.25e-06	5.1e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PDGFRB—hematologic cancer	2.25e-06	5.09e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NUP98—hematologic cancer	2.24e-06	5.07e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CG—hematologic cancer	2.22e-06	5.03e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CG—hematologic cancer	2.22e-06	5.03e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PDGFRA—hematologic cancer	2.21e-06	5.01e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—JAK1—hematologic cancer	2.2e-06	4.99e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PRKCG—hematologic cancer	2.2e-06	4.99e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CB—hematologic cancer	2.2e-06	4.98e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ADCY7—hematologic cancer	2.17e-06	4.92e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NCOA3—hematologic cancer	2.17e-06	4.92e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.17e-06	4.91e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NUP214—hematologic cancer	2.16e-06	4.89e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—MTHFR—hematologic cancer	2.15e-06	4.88e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.14e-06	4.84e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.13e-06	4.84e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTEN—hematologic cancer	2.13e-06	4.82e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	2.12e-06	4.81e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—MTR—hematologic cancer	2.11e-06	4.79e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCG2—hematologic cancer	2.11e-06	4.79e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTP1—hematologic cancer	2.1e-06	4.77e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CB—hematologic cancer	2.09e-06	4.74e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ENO2—hematologic cancer	2.07e-06	4.7e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CREBBP—hematologic cancer	2.06e-06	4.66e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CREBBP—hematologic cancer	2.06e-06	4.66e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CD44—hematologic cancer	2.04e-06	4.63e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NQO1—hematologic cancer	2.04e-06	4.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MTHFR—hematologic cancer	2.04e-06	4.62e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.04e-06	4.61e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TERT—hematologic cancer	2.04e-06	4.61e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HLA-A—hematologic cancer	2.04e-06	4.61e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—EP300—hematologic cancer	2.03e-06	4.6e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IL2—hematologic cancer	2.02e-06	4.57e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTT1—hematologic cancer	2.01e-06	4.56e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2e-06	4.53e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ABCB1—hematologic cancer	1.99e-06	4.51e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PDGFB—hematologic cancer	1.99e-06	4.5e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.98e-06	4.49e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SDC1—hematologic cancer	1.97e-06	4.45e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CD—hematologic cancer	1.95e-06	4.42e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CD—hematologic cancer	1.95e-06	4.42e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TSC2—hematologic cancer	1.94e-06	4.4e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NCOR1—hematologic cancer	1.93e-06	4.38e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTM1—hematologic cancer	1.93e-06	4.38e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYCS—hematologic cancer	1.93e-06	4.38e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ALB—hematologic cancer	1.93e-06	4.36e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ALB—hematologic cancer	1.93e-06	4.36e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—HSP90AA1—hematologic cancer	1.92e-06	4.35e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.9e-06	4.3e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.88e-06	4.25e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FGFR3—hematologic cancer	1.87e-06	4.23e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.85e-06	4.2e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3R1—hematologic cancer	1.84e-06	4.17e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3R1—hematologic cancer	1.84e-06	4.17e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—EP300—hematologic cancer	1.81e-06	4.1e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CG—hematologic cancer	1.81e-06	4.1e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTEN—hematologic cancer	1.81e-06	4.1e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.77e-06	4.02e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—BAD—hematologic cancer	1.77e-06	4.01e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—SRC—hematologic cancer	1.76e-06	3.99e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NOTCH1—hematologic cancer	1.75e-06	3.97e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.73e-06	3.91e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—EP300—hematologic cancer	1.72e-06	3.91e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CD80—hematologic cancer	1.72e-06	3.89e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KIT—hematologic cancer	1.71e-06	3.89e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—VEGFA—hematologic cancer	1.71e-06	3.88e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—MTHFR—hematologic cancer	1.71e-06	3.87e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTP1—hematologic cancer	1.7e-06	3.86e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CB—hematologic cancer	1.7e-06	3.85e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CB—hematologic cancer	1.7e-06	3.85e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NRAS—hematologic cancer	1.69e-06	3.84e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PTPN11—hematologic cancer	1.68e-06	3.82e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CREBBP—hematologic cancer	1.68e-06	3.8e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CD44—hematologic cancer	1.67e-06	3.79e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NQO1—hematologic cancer	1.67e-06	3.79e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.65e-06	3.73e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.64e-06	3.71e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CREB1—hematologic cancer	1.63e-06	3.7e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—MAPK3—hematologic cancer	1.62e-06	3.67e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—BRAF—hematologic cancer	1.61e-06	3.65e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ABCB1—hematologic cancer	1.61e-06	3.65e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—IL6R—hematologic cancer	1.59e-06	3.61e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CD—hematologic cancer	1.59e-06	3.6e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CREBBP—hematologic cancer	1.59e-06	3.6e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYCS—hematologic cancer	1.58e-06	3.58e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TGFB1—hematologic cancer	1.57e-06	3.56e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.57e-06	3.56e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ALB—hematologic cancer	1.57e-06	3.56e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTM1—hematologic cancer	1.56e-06	3.55e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NCOR1—hematologic cancer	1.56e-06	3.55e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MAP2K1—hematologic cancer	1.52e-06	3.44e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CD—hematologic cancer	1.51e-06	3.42e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.51e-06	3.41e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3R1—hematologic cancer	1.5e-06	3.4e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CA—hematologic cancer	1.5e-06	3.4e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTEN—hematologic cancer	1.47e-06	3.33e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTEN—hematologic cancer	1.47e-06	3.33e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—KRAS—hematologic cancer	1.46e-06	3.3e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FGF2—hematologic cancer	1.44e-06	3.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CG—hematologic cancer	1.44e-06	3.25e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3R1—hematologic cancer	1.42e-06	3.23e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.41e-06	3.2e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—EP300—hematologic cancer	1.4e-06	3.18e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—EP300—hematologic cancer	1.4e-06	3.18e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.39e-06	3.16e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CB—hematologic cancer	1.39e-06	3.14e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—JAK2—hematologic cancer	1.38e-06	3.14e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—MTHFR—hematologic cancer	1.38e-06	3.13e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MDM2—hematologic cancer	1.35e-06	3.06e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.35e-06	3.06e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CA—hematologic cancer	1.34e-06	3.03e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CREBBP—hematologic cancer	1.33e-06	3.02e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.32e-06	2.99e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CB—hematologic cancer	1.31e-06	2.98e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MTOR—hematologic cancer	1.31e-06	2.98e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CD4—hematologic cancer	1.31e-06	2.97e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—hematologic cancer	1.29e-06	2.93e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.28e-06	2.9e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.28e-06	2.9e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CA—hematologic cancer	1.28e-06	2.89e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CD—hematologic cancer	1.26e-06	2.86e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ALB—hematologic cancer	1.25e-06	2.82e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—HRAS—hematologic cancer	1.24e-06	2.81e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN1B—hematologic cancer	1.23e-06	2.79e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKT1—hematologic cancer	1.23e-06	2.78e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.22e-06	2.76e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTEN—hematologic cancer	1.2e-06	2.71e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3R1—hematologic cancer	1.19e-06	2.7e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CG—hematologic cancer	1.16e-06	2.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—EP300—hematologic cancer	1.14e-06	2.59e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN1A—hematologic cancer	1.14e-06	2.58e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PTEN—hematologic cancer	1.14e-06	2.57e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.13e-06	2.56e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CB—hematologic cancer	1.1e-06	2.49e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—AKT1—hematologic cancer	1.09e-06	2.48e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EP300—hematologic cancer	1.08e-06	2.45e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CREBBP—hematologic cancer	1.08e-06	2.44e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—SRC—hematologic cancer	1.05e-06	2.39e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKT1—hematologic cancer	1.04e-06	2.36e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CA—hematologic cancer	1.04e-06	2.35e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CA—hematologic cancer	1.04e-06	2.35e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CD—hematologic cancer	1.02e-06	2.31e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—STAT3—hematologic cancer	1.02e-06	2.3e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NRAS—hematologic cancer	1.01e-06	2.3e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.97e-07	2.26e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MAPK3—hematologic cancer	9.7e-07	2.2e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3R1—hematologic cancer	9.64e-07	2.19e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CG—hematologic cancer	9.51e-07	2.16e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PTEN—hematologic cancer	9.51e-07	2.15e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MYC—hematologic cancer	9.43e-07	2.14e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TGFB1—hematologic cancer	9.41e-07	2.13e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—EP300—hematologic cancer	9.07e-07	2.05e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CB—hematologic cancer	8.9e-07	2.02e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CREBBP—hematologic cancer	8.82e-07	2e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KRAS—hematologic cancer	8.72e-07	1.98e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKT1—hematologic cancer	8.47e-07	1.92e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKT1—hematologic cancer	8.47e-07	1.92e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CA—hematologic cancer	8.45e-07	1.91e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CD—hematologic cancer	8.36e-07	1.89e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALB—hematologic cancer	8.25e-07	1.87e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CA—hematologic cancer	8.01e-07	1.82e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3R1—hematologic cancer	7.89e-07	1.79e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTEN—hematologic cancer	7.69e-07	1.74e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HRAS—hematologic cancer	7.41e-07	1.68e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—EP300—hematologic cancer	7.34e-07	1.66e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CB—hematologic cancer	7.29e-07	1.65e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—IL6—hematologic cancer	7.09e-07	1.61e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKT1—hematologic cancer	6.9e-07	1.56e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CA—hematologic cancer	6.71e-07	1.52e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKT1—hematologic cancer	6.54e-07	1.48e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTEN—hematologic cancer	6.3e-07	1.43e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—EP300—hematologic cancer	6e-07	1.36e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKT1—hematologic cancer	5.48e-07	1.24e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CA—hematologic cancer	5.43e-07	1.23e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CA—hematologic cancer	4.44e-07	1.01e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKT1—hematologic cancer	4.43e-07	1e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKT1—hematologic cancer	3.63e-07	8.22e-06	CbGpPWpGaD
